Carboline, diketopiperazine, and purine derivatives for oncology drug discovery targeting p53, integrins, and cadherins
Three novel small-molecule scaffolds developed for cancer drug discovery: carboline derivatives as MDM2 inhibitors targeting the p53 pathway, diketopiperazine compounds designed as integrin ligands for angiogenesis inhib...